EMA Authorised: Beromun (tasonermin) — Belpharma s.a.

View source ↗

Summary

Beromun (tasonermin) has been authorised in the EU for use in sarcoma by Belpharma s.a.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Beromun (tasonermin)

Snippet

Status: Authorised. Therapeutic area: Sarcoma. MAH: Belpharma s.a.. Decision date: 09/12/2021